These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 849323

  • 1. Inhibition of the haemolytic complement activity by derivatives of benzamidine.
    Hauptmann J, Markwardt F.
    Biochem Pharmacol; 1977 Feb 15; 26(4):325-9. PubMed ID: 849323
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of guinea-pig complement by derivatives of benzamidine. I. Effect of p-nitrophenylureido derivative of m-(m-phenoxypropoxy)benzamidine on guinea-pig complement component haemolytic activity.
    Glovsky MM, Cory M, Alenty A.
    Immunology; 1974 Apr 15; 26(4):819-29. PubMed ID: 4136824
    [Abstract] [Full Text] [Related]

  • 3. Irreversible enzyme inhibitors. CLXIV. Proteolytic enzymes. XIV. Inhibition of guinea pig complement by meta-substituted benzamidines.
    Baker BR, Cory M.
    J Med Chem; 1969 Nov 15; 12(6):1049-52. PubMed ID: 5389146
    [No Abstract] [Full Text] [Related]

  • 4. Comparative inhibition of thrombin, plasmin, trypsin, and complement by benzamidines using substituent constants and regression analysis.
    Coats EA.
    J Med Chem; 1973 Oct 15; 16(10):1102-6. PubMed ID: 4270699
    [No Abstract] [Full Text] [Related]

  • 5. A comprehensive study on the mechanism of inhibition of serine proteases by benzamidines based on quantitative structure-activity relationship studies.
    Gupta SP, Handa A, Shewade DG.
    Arzneimittelforschung; 1987 Jan 15; 37(1):47-50. PubMed ID: 2952126
    [Abstract] [Full Text] [Related]

  • 6. A comparative QSAR study of benzamidines complement-inhibitory activity and benzene derivatives acute toxicity.
    Basak SC, Gute BD, Lucić B, Nikolić S, Trinajstić N.
    Comput Chem; 2000 Mar 15; 24(2):181-91. PubMed ID: 10719637
    [Abstract] [Full Text] [Related]

  • 7. Irreversible enzyme inhibitors. 186. Irreversible inhibitors of the C'la component of complement derived from m-(phenoxypropoxy)benzamidine by bridging to a terminal sulfonyl fluoride.
    Baker BR, Cory M.
    J Med Chem; 1971 Sep 15; 14(9):805-8. PubMed ID: 5140007
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of four human serine proteases by substituted benzamidines.
    Andrews JM, Roman DP, Bing DH.
    J Med Chem; 1978 Dec 15; 21(12):1202-7. PubMed ID: 152812
    [Abstract] [Full Text] [Related]

  • 9. Haemolytic effect of the scorpion Heterometrus fulvipes venom.
    Venkaiah B, Parthasarathy PR, Krishnaswamy S.
    Biochem Int; 1983 Aug 15; 7(2):241-5. PubMed ID: 6679342
    [Abstract] [Full Text] [Related]

  • 10. Structure-activity relationships for the inhibition of acrosin by benzamidine derivatives.
    Parrish RF, Straus JW, Paulson JD, Polakoski KL, Tidwell RR, Geratz JD, Stevens FM.
    J Med Chem; 1978 Nov 15; 21(11):1132-6. PubMed ID: 722718
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of serine proteinases by benzamidine derivatives.
    Walsmann P.
    Acta Biol Med Ger; 1977 Nov 15; 36(11-12):1931-7. PubMed ID: 616739
    [Abstract] [Full Text] [Related]

  • 12. [Synthetic inhibitors of serine proteinases. 35. Inhibition action of amidino- and guanidinophenyl derivatives against hemolysis initiated by complement activation].
    Hoffmann A, Markwardt F.
    Pharmazie; 1989 Feb 15; 44(2):141-4. PubMed ID: 2748697
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of acrosin by benzamidines.
    Stürzebecher J.
    Acta Biol Med Ger; 1981 Feb 15; 40(10-11):1519-22. PubMed ID: 7044006
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of C1s-induced vascular leakage in guinea pigs by substituted benzamidine and pyridinium compounds.
    Andrews JM, Rosen FS, Silverberg SJ, Cory M, Schneeberger EE, Bing DH.
    J Immunol; 1977 Feb 15; 118(2):466-71. PubMed ID: 320260
    [Abstract] [Full Text] [Related]

  • 15. [Synthetic inhibitors of serine proteinases. 17. The effect of benzamidine derivatives on the activity of urokinase and the reduction of fibrinolysis].
    Stürzebecher J, Markwardt F.
    Pharmazie; 1978 Sep 15; 33(9):599-602. PubMed ID: 733877
    [No Abstract] [Full Text] [Related]

  • 16. Individual differences in the sensitivity of sheep erythrocytes to the hemolytic action of serum complement and hemolysin.
    Truszczyński M, Borkowska B, Kogut L.
    Arch Immunol Ther Exp (Warsz); 1966 Sep 15; 14(3):306-10. PubMed ID: 5919646
    [No Abstract] [Full Text] [Related]

  • 17. Irreversible enzyme inhibitors. CLII. Proteolytic enzymes. X. Inhibition of guinea pig complement by substituted benzamidines.
    Baker BR, Erickson EH.
    J Med Chem; 1969 May 15; 12(3):408-14. PubMed ID: 5788155
    [No Abstract] [Full Text] [Related]

  • 18. Prediction of complement-inhibitory activity of benzamidines using topological and geometric parameters.
    Basak SC, Gute BD, Ghatak S.
    J Chem Inf Comput Sci; 1999 May 15; 39(2):255-60. PubMed ID: 10328686
    [Abstract] [Full Text] [Related]

  • 19. Latent effects of haemolytic agents.
    Bergmann F, Kidron M.
    J Gen Microbiol; 1966 Aug 15; 44(2):233-40. PubMed ID: 5969501
    [No Abstract] [Full Text] [Related]

  • 20. Novel bis(benzamidino) compounds with an aromatic central link. Inhibitors of thrombin, pancreatic kallikrein, trypsin, and complement.
    Geratz JD, Cheng MC, Tidwell RR.
    J Med Chem; 1976 May 15; 19(5):634-9. PubMed ID: 1271404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.